header logo Pharma Manufacturing

The drug industry's voice for manufacturing excellence

  • Production
  • Development
  • Information Technology
  • Compliance
  • Quality & Risk
Pharma Manufacturing mega-logo
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
  • Home >
  • Back Issues >
  • Pharma Manufacturing >
  • April 2023
  • April 2023

    April 2023 Pharma Manufacturing
    April 2023 cover image
    April 2023
    Subscribe
    Digital Edition
    Archives
    Renew
    Pm22 Hero 854x480 Web
    Home

    Assuring generic access evermore

    April 24, 2023
    Pm2304 Hero 854x480 Culture
    Home

    Weathering the workforce storm

    April 20, 2023
    Pm2304 Hero 854x480 Operations
    Unit Operations

    Beating the space crunch

    April 19, 2023
    Shutterstock 2033719064
    Home

    A practical approach to DX in ATMPs

    April 17, 2023
    Shutterstock 423625090
    Home

    Is pharma prepared for a TiO2 ban?

    April 12, 2023
    footer logo Pharma Manufacturing
    Helping drugmarkers leverage technology and best practices to bring new therapies to market at scale—quickly, safely and efficiently
    Newsletters
    The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.
    Connect
    Follow us for the latest industry news and insights.
    https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
    http://www.linkedin.com/groups?gid=1813799
    http://twitter.com/PharmaMfg
    • About Us
    • Advertise
    • Do Not Sell or Share
    • Privacy Policy
    • Terms & Conditions
    EndeavorB2B Logo
    © 2025 All rights reserved.